Publication in NPJ Vaccines highlights delivery of DNA vaccine with PharmaJet Needle-free IM System produces robust and ...

When giving gluteal injections, it is safest to use the upper outer quadrant. The choice of site for injection must be based on good clinical judgment, using the best evidence available and ...

Stop throwing away your beef grease. We'll show you exactly how to store and cook with this incredibly rich flavor carrier.

Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free ...

Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free survival in patients with endocrine therapy-pretreated, ER-positive, ...

A groundbreaking international study has found that imlunestrant plus abemaciclib significantly improved progression-free survival (PFS) versus imlunestrant monotherapy in patients with estrogen ...

It looks like Eli Lilly’s oral selective estrogen receptor degrader (SERD) imlunestrant may need some extra help to reach a ...

With a starting weight of 850 pounds and a goal end weight of around 1,350 pounds, Lancaster said that steer will need to ...

The DDL Conference, taking place in Edinburgh, Scotland, attracts over 1,000 global experts annually, including scientists, clinicians, and industry leaders. Belhaven Biopharma will present these ...

Results of the a phase III clinical trial called EMBER-3 indicate the promise and efficacy of a drug called imlunestrant. This is a new kind of oral selective estrogen receptor degrader (SERD), used ...

An experimental drug stops advanced breast cancer from progressing in some people with tumors that have grown resistant to ...

Eli Lilly (LLY) announced results from the Phase 3 EMBER-3 study of imlunestrant, an investigational, oral selective estrogen receptor ...